DEVELOPING INNOVATIVE VACCINES
PROTECTING PEOPLE
Alpha-O Peptides develops innovative technologies in therapeutics and biotechnology and provides licenses to qualified industry partners. Below is an overview of our current patent portfolio and active patent applications, most of which are filed in major global markets:
-
US8575110-B2 – Peptidic nanoparticles for drug delivery and antigen display
Expiry date: September 19, 2028 -
US8546337-B2 – Self-assembling peptide nanoparticles for vaccine applications
Expiry date: October 17, 2029 -
US10245318-B2 – Flagellin-containing protein nanoparticles as a vaccine platform
Expiry date: January 9, 2035 -
US20240075120-A1 – Self-assembling protein nanoparticles encapsulating immunostimulatory nucleic acids
Anticipated expiry date: April 7, 2043 -
US20200017554-A1 – Self-assembling protein nanoparticles featuring an integrated six-helix bundle protein
Anticipated expiry date: May 30, 2042 -
US63/873,012 – Self-assembling protein nanoparticles incorporating histidines
Anticipated expiry date: August 29, 2046
For inquiries, please contact us at:
